Strongbridge Biopharma plc

CIK 1634432 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Strongbridge Biopharma plc.

Recent SEC filings

FiledFormAccession number
Feb 11, 2022SC 13G/A0000947871-22-000214
Jan 5, 2022SC 13D/A0000919574-22-000045
Jan 5, 202240000919574-22-000043
Oct 25, 2021SC 13D/A0001072613-21-000606
Oct 15, 202115-12B0001193125-21-300045
Oct 6, 2021EFFECT9999999995-21-003792
Oct 6, 202140001179110-21-009277
Oct 6, 202140001179110-21-009282
Oct 6, 2021EFFECT9999999995-21-003791
Oct 6, 202140001179110-21-009281
Oct 6, 202140001179110-21-009284
Oct 6, 202140001179110-21-009278
Oct 6, 2021EFFECT9999999995-21-003794
Oct 6, 202140001179110-21-009283
Oct 6, 202140001179110-21-009276
Oct 6, 202140001179110-21-009280
Oct 6, 202140001179110-21-009279
Oct 6, 202140001179110-21-009285
Oct 5, 202140001179110-21-009219
Oct 5, 202140001179110-21-009218
Oct 5, 202140001179110-21-009223
Oct 5, 2021POS AM0001104659-21-123133
Oct 5, 2021POS AM0001104659-21-123124
Oct 5, 2021S-8 POS0001104659-21-123151
Oct 5, 2021S-8 POS0001104659-21-123150